Injectables

Injectables (also knownas injection pens) are increasingly used forweight loss. Ozempic (semaglutide) and Saxenda (liraglutide) are GLP-1 receptor agonists that reduce appetite, slow gastric emptying, and increase insulin production. This helps control blood sugar levels better and promotes weight loss. Wegovy, a higher dosage of semaglutide, is specifically approved for weight loss in people with obesity or overweight and health issues. These injectables are an alternative to traditional methods suchas diet and exercise, especially for people who struggle to lose weight through conventional means.It is important to use injectables for weight loss only under a doctor's supervision, as these medication scan also have side effects.

The effectiveness of these medications has led to increasing global popularity, aided by positive results in clinical studies showing significant weight reduction. They work by suppressing appetite and creating a feeling of fullness. However, medical weight loss with injections also brings new challenges in terms of nutrition and health. Because injectables reduce appetite, you eat less and risk not getting all the essential nutrients. This can lead to deficiencies in vitamins and minerals crucial for your health.

Introducing Elan's Balance tablets

At Elan, we are proud to announce the launch of our newest product: Elan's Balance tablets. This groundbreaking dietary supplement is specially designed for users of GLP-1 medication. As the first company in the world to develop a dietary supplement for this specific target group, we are setting a new standard in nutritional support for responsible medical weight loss with injectables under medical supervision. Elan's Balance tablets are carefully formulated in collaboration with medical specialists to perfectly meet the nutritional needs of people who are medically losing weight with injectables.